May
Medicinal Chemistry
Strategy Meeting East Coast USA 2024
Reinvigorating Productivity in Pharma & Biotech R&D Through Advanced Technologies and Innovative Techniques that Interrogate Activity and Mechanisms
What makes our strategy meetings unique?
Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.
Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.
Jim LaRocque
VSenior Research Scientist III, Assay Development & Screening CuriaMark Wolf
Director, Medicinal Chemistry CuriaMatthew Surman
Associate Director, Medicinal Chemistry CuriaHelena Almqvist
Project Advisor, Business Development Pelago BioscienceRick Ewing
VP, Head of Chemistry Rapafusyn PharmaceuticalsAbhijat Vatsyayan
Head of Artificial Intelligence Taiho OncologyAndrew Zhang
Director, Head of Chemical Biology AstraZenecaDavid James
Senior VP Business Development eMoleculesErnane Souza, PhD, RPh
Assistant Director, Translational PKPD and DMPK Supernus Pharmaceuticals IncEileen Carry
Founder & CEO Zena Therapeutics IncFrank Leu
Founder & Managing Member/ Managing Member BioPharMatrix LLC/ Novapeutics LLCGunaretnam Rajagopal
Venture Partner Samsara BiocapitalHuijun Wang
Head of Computational Drug Design Deerfield ManagementML Ujwal
Associate Director, Data Science JanssenTanweer Khan
Director, Discovery Chemistry aTai Life SciencesDongming Shen
Vice President Chemistry Viva Star BiosciencesYushma Bhurruth-Alcor
Executive Director Of Chemistry Remedy Plan TherapeuticsSee Which Topics Are Discussed at the Strategy Meeting
Non-Degrading molecular Glues for Discovering Inhibitors for Hard to Drug Targets
Roundtable Tracks
1Advancing The Frontier Harnessing Deep Learning And Generative Ai For Molecule Design And Optimization In Chemistry
-Abhijat Vatsyayan
Head of Artificial Intelligence
Taiho Oncology
Innovative and Emerging Modalities
Examining The Mechanism And Effects Of Induced Proximity Modalities
Chemical Biology, Targeted Protein Degradation & Undruggables
Pioneering Chemical and Proteomics Approaches: Unraveling Efficacy and Safety in Small Molecule and Protein Degradation Across Multiple Therapeutic Frontiers
-Andrew Zhang
Director, Head of Chemical Biology
AstraZeneca
Hit Identification / Lead Optimization
Using Computational Methods To Improve Precision And Efficiency In Lead Optimization And Hit Identification
-Huijun Wang
Head of Computational Drug Design
Deerfield Management
Integrated Drug Discovery
Challenges of the CNS Drug Discovery and Development (Topic TBC)
-Ed Kesicki
Associate Vice President – Discovery Strategy and Operation
Loxo Oncology
Roundtable Tracks
2The Utility of Ultra-Large Virtual Chemical Spaces Opportunities Challenges And What’s Next?
eMolecules
Innovative and Emerging ModalitiesInvestigating The Application Of DELs For The Discovery Of Other Modalities
SPONSOR
Chemical Biology, Targeted Protein Degradation & UndruggablesOvercoming Drug Resistance And Undruggable Targets With Chemical Biology And Targeted Protein Degradation
SPONSOR
Hit Identification / Lead OptimizationUnderstanding The Future Of High Throughput Screening And How We Might Be Able To Reach Undruggable Targets
SPONSOR
Integrated Drug DiscoveryThe Future Of Computer Aided Drug Design (CADD) In Various Stages Of The Drug Development Pipelines As Well As Pharma Technological Advances
SPONSOR
Roundtable Tracks
3Implementing De Novo For Generative Models To Molecular Design On Drug Projects
Innovative and Emerging Modalities
Unveiling The Next Wave Of Drug Discovery Discovering Cutting Edge Technologies And Approaches
-Tanweer Khan
Director, Discovery Chemistry
aTai Life Sciences
Chemical Biology, Targeted Protein Degradation & Undruggables
Identifying “Difficult-to-Drug” Targets with Chemical Biology Approaches
-Andrew Zhang
Director, Head of Chemical Biology
AstraZeneca
Hit Identification / Lead Optimization
Efforts For “Failing Fast And Failing Early” ie.., What To Do Early In Lead Generation And Lead Optimization
-Dongming Shen
Vice President Chemistry
Viva Star Biosciences
Integrated Drug Discovery
Tackling The Challenges And Leveraging The Potential Of Cryo-EM In Drug Discovery
-Eileen Carry
Founder & CEO
Zena Therapeutics Inc
Roundtable Tracks
4Exploiting The Selectivity And Efficiency Of Enzymes In Complex Molecule Synthesis (Topic TBC)
-ML Ujwal
Associate Director, Data Science
Janssen
Innovative and Emerging Modalities
Innovating The Future Of Healthcare:
Integrating AI, Data Science, Genetics And Genomics Into Biotech & Pharma R&D Strategies
-Gunaretnam Rajagopal
Venture Partner
Samsara Biocapital
Chemical Biology, Targeted Protein Degradation & Undruggables
Methods Of Computation And Cheminformatics For Chemical Synthesis And Hit Finding For Tough Targets And New Therapeutic Approaches
Hit Identification / Lead Optimization
How Are Biomarkers and Integrative Approaches Guiding Hit Identification and Lead Optimization for Accelerated Drug Development?
-Yushma Bhurruth-Alcor
Executive Director Of Chemistry
Remedy Plan Therapeutics
Integrated Drug Discovery
Exploring Translational Challenges And Triumphs In Integrated Drug Discovery For Real-World Clinical Impact
Bridging Science and Investment: A Dialogue on Drug Discovery, Venture Strategies, Biotech Progress, and the Revolutionary Landscape of Pharmaceuticals
Reasons To Attend Our Strategy Meetings
Fully Interactive Format
There’s only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter
Senior Decision Makers
All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard
Personalised Agendas
Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we’ll create a personalised agenda just for you
Private and Intimate Networking
Small group discussions, private meetings, networking drinks – however you choose to make those important connections our Strategy Meetings have the solution
Become an official strategy meeting partner
Whatever your business needs, we can help. Get in touch for partnering opportunitiesPress play to hear what your colleagues had to say...
Hotel & Venue
Hyatt Regency Princeton
Hyatt Regency Princeton hotel is conveniently located near corporate offices and attractions, as well as the Mercer County Airport.
Hotel Details Map & Directions ParkingHere To Help
Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.